{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-273544","form_type":"8-K","ticker":"BOLD","cik":"0001782303","company_name":"Boundless Bio, Inc.","filed_at":"2026-06-17T14:49:04+00:00","discovered_at":"2026-06-17T14:50:03.898204+00:00","generated_at":"2026-06-17T14:50:13.259539+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Boundless Bio shareholders elect two directors, ratify KPMG as auditor at annual meeting","bullets":["Dr. James Christensen and Jennifer Lew elected as Class II directors with over 9.2M votes for each.","Ratification of KPMG LLP as independent auditor for FY 2026 approved with 15.4M votes for, 127.7K against.","Annual meeting held June 15, 2026; all proposals passed as recommended by board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-273544","json":"https://secwatch.observer/filing/0001193125-26-273544.json","markdown":"https://secwatch.observer/filing/0001193125-26-273544.md","text":"https://secwatch.observer/filing/0001193125-26-273544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526273544/0001193125-26-273544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526273544/bold-20260615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T14:50:13.259539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05ab090a4f5eb036f13bff541968bf0412aa02f5","claim":"Boundless Bio, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-06-15 meeting.","evidence_excerpt":"Proposal 2: The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the votes set forth below. Votes For Votes Against Abstentions Broker Non-Votes 15,376,973 127,747 52,066 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526273544/0001193125-26-273544-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"23955a2dbddde859e73b61570378ef83f28df381","claim":"Boundless Bio, Inc. shareholders approved Election of Class II Directors at the 2026-06-15 meeting.","evidence_excerpt":"Proposal 1 : Each of the director nominees was elected as a Class II director to hold office until the Company’s 2029 annual meeting of stockholders, and until their respective successor is duly elected and qualified, by the votes set forth below. Nominee Votes For Votes Withheld Broker Non‐Votes James Christensen, Ph.D. 9,287,096 512,585 5,757,105 Jennifer Lew 9,271,084 528,597 5,757,105","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526273544/0001193125-26-273544-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}